Biomarkers in Chemotherapy-Induced Peripheral Neurotoxicity

NACompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

February 14, 2022

Study Completion Date

February 14, 2022

Conditions
CIPN - Chemotherapy-Induced Peripheral Neuropathy
Interventions
DIAGNOSTIC_TEST

EPR Oximetry

Subjects will have up to five EPR oximetry readings at each study visit. Subjects will place the foot with the paramagnetic ink injection between the two magnets of the EPR device. Continuous scans will be acquired for 10 minutes while the subject breathes room air, 10 minutes while the subject breathes enriched 100% oxygen, and 10 minutes while breathing room air again.

Trial Locations (1)

03766

Dartmouth-Hitchcock Medical Center in Lebanon, NH, Lebanon

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Disarm Therapeutics

INDUSTRY

lead

Dartmouth-Hitchcock Medical Center

OTHER